Tags:BiopharmaBuildingDataDrugLabPersonalPlatformRoboticsScienceService
Notable Labs works to determine what drugs could be potential treatments for brain cancer Notable Labs is a translational drug discovery platform focused on identifying therapeutic options for cancer patients. Clinical lab service: We help doctors identify personalized combinations of FDA-approved treatments for their cancer patients. Focusing on individual patients + existing treatments, we?re discovering new uses of drugs and defining mechanisms underlying cancer progression and drug resistance. Using robotic + modern data science, we?re building a scalable, iterative model that will turn individual treatment selection into a data problem. R&D platform: The clinical lab service acts as a funnel to acquire primary patient samples for biopharma partnerships. Using our automated, multi-parametric drug screening research platform, collaborators can assay the biological impact of compounds on primary cells in a physiologically relevant environment. This platform helps our partners stratify patients, de-risking drug development and increasing their probability of success.
Location: United States, Foster City
Member count: 11-50
Total raised: $50M

Investors 11

Show more

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
16.07.2019Series B$40M-Notable Na...
06.09.2017Series A$10M-Notable La...

Mentions in press and media 17

DateTitleDescriptionCategoryAuthorSource
23.01.2020Notable La...– Notable launches The ANSWe...-Fred Penni...hitconsult...
14.10.2019When will ...Hear from Data Collective, Doc...-Kristin Ka...vator.tv/n...
19.09.2019Where heal...Kaiser Ventures, Evidation Hea...-Steven Loe...vator.tv/n...
11.09.2019At #Invent...Executives from Doctor On Dema...-Steven Loe...vator.tv/n...
17.07.2019Notable Na...Notable, a San Francisco, CA-b...-Fred Penni...hitconsult...
16.07.2019Notable ra...Update: Notable has raised $40...-Kyle Wigge...venturebea...
16.07.2019Notable Ra...Notable, a Foster City, Califo...USA-finsmes.co...
15.05.2019With new c...“It’s something that we’...--medcitynew...
09.05.2019Don’t mi...A panel discussion will explor...--medcitynew...
15.04.2019Stanford, ...The study – which was focuse...--medcitynew...
Show more